🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Tamsulosin Hydrochloride OCAS 0.4 mg

Found 12 matching trials

Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

PHASE2

A study to evaluate the safety of the co-administration of solifenacin succ...

Status

Completed

Location

Multiple Locations

Start Date

2007-06

Trial ID

NCT00507455

Treatments Being Tested

solifenacin succinate tamsulosin hydrochloride Placebo to solifenacin Placebo to tamsulosin

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms

PHASE3

Clinical study to examine the safety, tolerability and efficacy of long-ter...

Status

Completed

Location

Multiple Locations

Start Date

2010-04-26

Trial ID

NCT01021332

Treatments Being Tested

tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)

Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones

PHASE4

This is a randomized double blind placebo-controlled study that will assess...

Status

Unknown

Location

Maharat Nakhon Chiangmai Hospital

Start Date

2010-06

Trial ID

NCT01167062

Treatments Being Tested

Tamsulosin Hydrochloride OCAS 0.4 mg Placebo

A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin 0.4 mg Tablets, in Healthy Adult Male Subjects, Under Fed Conditions

PHASE1

The aim of this study is to evaluate the bioequivalence and safety of Tamsu...

Status

Active Not Recruiting

Location

"Tonus-Les" LLC

Start Date

2025-06-16

Trial ID

NCT07091669

Treatments Being Tested

Tamsulosin (0.4 mg/j)Tamsulosin (0.4 mg/j)

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms

PHASE3

Clinical study to examine the efficacy, safety and tolerability of combinat...

Status

Completed

Location

Multiple Locations

Start Date

2010-01-11

Trial ID

NCT01018511

Treatments Being Tested

Placebo tamsulosin hydrochloride OCAS 0.4 mg Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg tamsulosin hydrochloride OCAS 0.4 mg tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg)tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg)

Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fed Conditions

Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...

Status

Completed

Location

Axis Clinicals Latina, S.A. de C.V.

Start Date

2026-02-12

Trial ID

NCT07698288

Treatments Being Tested

Tamsulosin 0.4 mg ER tablet Tamsulosin 0.4 mg ER tablet

A Comparative Bioavalability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tabsulosine 0.4 mg Tablets in Healthy Adult Male Subjects, at Steady State

PHASE1

The aim of this study is to evaluate the bioequivalence and safety of Tamsu...

Status

Active Not Recruiting

Location

"Tonus-Les" LLC

Start Date

2025-03-03

Trial ID

NCT07146711

Treatments Being Tested

Tamsulosin (0.4 mg/j)Omnic Ocas®,

Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fasted Conditions

Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...

Status

Completed

Location

Axis Clinicals Latina, S.A. de C.V.

Start Date

2026-01-12

Trial ID

NCT07698275

Treatments Being Tested

TAMSULOSIN TEST OMNIC OCAS REFERENCE

A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

PHASE4

Randomized, double-blind, placebo-controlled study with two treatment arms ...

Status

Completed

Location

Multiple Locations

Start Date

2005-10

Trial ID

NCT00379067

Treatments Being Tested

Tamsulosin OCAS Placebo

Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film-coated Tablets

PHASE1

This study was an open-label, randomized, single-dose, four-period, two-seq...

Status

Completed

Location

PT Equilab International

Start Date

2023-11-06

Trial ID

NCT06558032

Treatments Being Tested

Tamsulosin 0.4 mg Sustained Release Tablet (produced by PT Dexa Medica, Indonesia)Harnal® OCAS 0.4 mg Prolonged Release Tablet (produced by Astellas Pharma Europe B.V., The Netherlands, imported by PT Combiphar, Indonesia)

Previous Next